Applied Evidence

B12 deficiency: A look beyond pernicious anemia

Author and Disclosure Information

 

References

Over the past 20 years, postsurgical malabsorption of B12 has been on the decline, due in large part to the decreasing frequency of gastrectomy and surgical resection of the terminal small intestine.1,2,5 There are, however, several disorders commonly seen in gastroenterology practice that may be associated with cobalamin malabsorption. These include deficiency in the exocrine function of the pancreas after chronic pancreatitis (usually alcoholic), lymphomas or tuberculosis (of the intestine), Crohn’s disease, Whipple’s disease, and occasionally celiac disease.3,13

Rounding out the list of causes of B12 deficiency is food-B12 malabsorption, which is the leading cause of B12 malabsorption—especially in elderly patients.1-4 In our own studies in which we have followed more than 300 patients with a documented B12 deficiency, food-B12 malabsorption accounts for about 60% to 70% of the cases of B12 deficiency in elderly patients, whereas pernicious anemia accounts for only 15% to 25%.5,24 In our study of 172 hospitalized patients with B12 deficiency (median age, 70), 53% had food-B12 malabsorption.5

A form of malabsorption that’s tough to spot

Food-B12 malabsorption is a syndrome characterized by the inability to release B12 from food or intestinal transport proteins, particularly in the presence of hypochlorhydria, in which the absorption of “unbound” B12 is normal. As various studies have shown,4,5,24 this syndrome is defined by B12 deficiency in the presence of sufficient food-B12 intake and normal Schilling test results, which rules out pernicious anemia. In theory, indisputable evidence of food-B12 malabsorption comes from using a modified Schilling test, which uses radioactive B12 bound to animal proteins (eg, salmon, trout) and reveals malabsorption when the results of a standard Schilling test are normal.1,5,24

Some authors have speculated about the significance of B12 deficiency related to food-cobalamin malabsorption,1 because many patients have only mild clinical or hematological features. Several of our patients, however, have had significant features classically associated with pernicious anemia, including polyneuropathy, confusion, dementia, medullar-combined sclerosis, anemia, and pancytopenia.5 Nevertheless, the partial nature of this form of malabsorption might produce a more slowly progressive depletion of B12 than does the more complete malabsorption engendered by disruption of intrinsic factor–mediated absorption. The slower progression of depletion probably explains why mild, preclinical deficiency is associated with food-B12 malabsorption more often than with pernicious anemia.1,5

H pylori, antacid use should raise suspicions

Food-B12 malabsorption is caused primarily by atrophic gastritis.5 More than 40% of patients older than 80 years have gastric atrophy that might (or might not) be related to H pylori infection.3,25 Other factors that contribute to food-B12 malabsorption in elderly people include:

  • Chronic carriage of H pylori and intestinal microbial proliferation (in which case B12 deficiency can be corrected by antibiotic treatment)25,26
  • Long-term ingestion of antacids, including H2-receptor antagonists and proton-pump inhibitors,27,28 particularly among patients with Zollinger-Ellison syndrome29,30
  • Long-term ingestion of biguanides (metformin)31-33
  • Chronic alcoholism
  • Surgery or gastric reconstruction (eg, bypass surgery for obesity)
  • Partial pancreatic exocrine failure1,5
  • Sjögren’s syndrome or systemic sclerosis34

In our research involving 92 elderly patients (mean age: 76 years) with food-B12 malabsorption,5 we found at least one of the associated conditions or agents listed at left in 60% of the patients. These conditions mainly included atrophic gastritis (H pylori infection) in 30% of the patients and long-term metformin or antacid intake in 20% of the elderly patients.

TABLE 2
French hospital findings support use of oral B12 treatment38-41,45

STUDY CHARACTERISTICS (NUMBER OF PATIENTS)THERAPEUTIC MODALITIESRESULTS
Open prospective study of well-documented vitamin B12 deficiency related to food-B12 and malabsorption (n=10)39Oral crystalline cyanocobalamin: 650 mcg per day, for at least 3 months
  • Normalization of serum vitamin B12 levels in 80% of the patients
  • Significant increase of hemoglobin (Hb) levels (mean of 1.9 g/dL) and decrease of mean erythrocyte cell volume (ECV) (mean of 7.8 fL)
  • Improvement of clinical abnormalities in 20% of the patients
  • No adverse effects
Open prospective study of low vitamin B12 levels not related to pernicious anemia (n=20)40Oral crystalline cyanocobalamin: between 1000 mcg per day for at least 1 week
  • Normalization of serum vitamin B12 levels in 85% of the patients
  • No adverse effects
Open prospective study of well-documented vitamin B12 deficiency related to food-B12 malabsorption (n=30)38Oral crystalline cyanocobalamin: between 250 and 1000 mcg per day, for 1 month
  • Normalization of serum vitamin B12 levels in 87% of the patients
  • Significant increase of Hb levels (mean of 0.6 g/dl) and decrease of ECV (mean of 3 fl); normalization of Hb levels and ECV in 54% and 100% of the patients, respectively
  • Therapeutic dose of vitamin B12 ≥500 mcg per day
  • No adverse effects
Open prospective study of low vitamin B12 levels not related to pernicious anemia (n=30)41Oral crystalline cyanocobalamin: between 125 and 1000 mcg per day for at least 1 week
  • Normalization of serum vitamin B12 levels in all patients with at least a dose of vitamin ≥250 mcg per day
  • Therapeutic dose of vitamin B12 ≥500 mcg per day
  • No adverse effects
Open prospective study of low vitamin B12 levels related to pernicious anemia (n=10)45Oral crystalline cyanocobalamin: 1000 mcg per day, for at least 3 months
  • Significant increase of serum vitamin B12 levels in 90% of the patients (mean of 117.4 pg/mL)
  • Significant increase of Hb levels (mean of 2.45 g/dL) and decrease of ECV (mean of 10.4 fL)
  • Improvement of clinical abnormalities in 30% of the patients

Recommended Reading

HbA1c Levels Reliably Predict Coronary Bypass Outcomes
MDedge Family Medicine
Combo Therapy Boosts Blood Pressure Control : Significant reductions in blood pressure were seen across all populations, including African Americans.
MDedge Family Medicine
Emotions Drive Angioplasty Rates for Patients With Stable CAD
MDedge Family Medicine
Warfarin Control Succeeds in Oldest AF Patients
MDedge Family Medicine
Mild Renal Issues Raise the Risk of Atrial Fibrillation
MDedge Family Medicine
Gastric Bypass Cuts Left Atrial Size, Heart Failure
MDedge Family Medicine
Total Thyroidectomy Successful for Larger Tumors
MDedge Family Medicine
TSH Range Is Not Universally Applicable
MDedge Family Medicine
In Benign Goiter, Unilateral Excision Is Best
MDedge Family Medicine
Algorithm Guides Thyroid Nodule Aspiration
MDedge Family Medicine